Sign up for our complimentary
weekly e-journal

Main Newsletter
Mastery Series
Therapy Series
 

Items for the Week

Ordered by most recent

FDA Approves J&J's Invokamet Combo (SGLT-2 + Metformin)

The US Food and Drug Administration has approved Invokamet, a fixed-dose therapy combining Invokana (canagliflozin) and metformin.... 


Should Non-diabetics Use Diabetes Drugs?

A study involving over 180,000 people showed that patients treated with metformin can live longer than non-diabetics.... 


The Importance of Control Solution

Control solution, used for ensuring the proper function of glucose meters, doesn't appear to be a priority among physicians, pharmacists, or patients.... 



Early Insulin Delays Diabetes But Are There Negative Consequences?

One researcher comments, "Please don't fall into this trap that you can prevent diabetes with insulin."…


Effects of Intensive Glycemic Control on Ischemic Heart Disease

How can three landmark trials of intensive vs standard glucose-lowering strategies -- ADVANCE, ACCORD, and VADT -- raise more questions than they answer?... 


Peripheral Neuropathy Associated with CV Disease and Stroke in Type 2 Diabetes Patients

Testing for peripheral neuropathy may provide a way to identify individuals at higher risk of cardiovascular events.... 


Dulaglutide vs. Exenatide as Add-On Therapy to Pioglitazone and Metformin in T2DM

Study seems to indicate superiority of dulaglutide, a long-acting GLP-1 receptor agonist that is administered once-weekly.... 


During Prolonged Low-Intensity Exercise, Caffeine Alters Blood Glucose

The effects of caffeine versus maltodextrin during exercise were observed in patients with type 2 diabetes.... 


A Link between Cesarean Delivery and Type 1 Diabetes?

Initial findings suggest relationship but with sibling-control analyses, effect almost disappears….


High BMI Can Improve GFR in Patients with Stage 3 or 4 CKD and Type 2 Diabetes

A BMI of more than 25 kg/m seems to be a protective factor for renal function deterioration in some patients.... 


Benefits of Tree Nuts in Glycemic Control

Displacement of high glycemic-index carbohydrates and high and monounsaturated fat content may explain the positive effects....


Amputation Rates Linked to Low-Income Neighborhoods in California

Rates for patients with diabetes are two times higher in low-income neighborhoods compared to high-income neighborhoods in California.... 


New Combination of Diabetes Drugs Have Synergistic Effect

Metformin and SGLT2 inhibitors together reduce the blood sugar levels of diabetics more effectively than either drug alone.... 


SGLT2 Inhibitor Empagliflozin Wins FDA OK

The glucose-reducing drug empagliflozin (Jardiance) won approval today from the US Food and Drug Administration (FDA) after Boehringer Ingelheim corrected manufacturing problems that caused the agency to say "no" in...


New Encapsulated Beta-Cell Replacement Therapy for Type 1 Diabetes

Beta cell encapsulation therapy is a procedure that involves implantation of cells with the ability to secrete insulin in a glucose-responsive manner in a protective barrier into the body....


Acarbose Treatment and the Reduction of CVD Risk in Type 2 Diabetes Patients

Previous studies have shown that decreasing postprandial hyperglycemia with acarbose could reduce the risk of CV events but a new study shows that risk may increase for the first 12 months of exposure…. 


Gender Differences in Control of Multiple CVD Risk Factors in Type 2 Diabetes Patients

Adjusted mean DBP levels found to be significantly higher in women compared to men but other risk factors were almost the same between genders….


Hypoglycemia Awareness improves with Self-Monitoring in Type 1 Diabetes

The best outcomes were achieved by multiple daily injections with self-monitoring of blood glucose.... 


Safe and Effective Closed Loop Insulin Delivery for Type 1's Decreases Hypo's

A new delivery system has been evaluated and found to be safe and effective for young adults to use at home without any supervision needed....


Metformin Treatment Provides Better Lipid Control

Better overall lipid effects were seen in type 2 diabetes patients with coronary artery disease treated with metformin than those being treated with glipizide....


Fasts OK for Diabetic Kids

A total daily insulin dose of about 0.2 U/kg was optimal to cover the fast day, "although there is considerable variability between patients."...


New Way to Regenerate Beta Cells in Type 1 Diabetes Patients

A peptide called caerulein converted existing cells in the pancreas into insulin-generating beta cells....


Hypertension Control Can Prevent Renal Damage in Diabetics

Elevated blood pressure is associated with an increased risk of renal damage in patients with type 2 diabetes, especially those with poor glycemic control....


The Prevalence of Diabetes among U.S. Latinos

Adequate glycemic control is 48% and health insurance coverage among Latino diabetics is 52.4%.... 


Low-carb Diet Recommended for Type 1 and 2 Diabetes Patients

Low-carbohydrate diets should be the first line of attack for treatment of type 2 diabetes, and should be used in conjunction with insulin in those with type 1 diabetes.... 


Connection between Type 1 Diabetes and Ulcerative Colitis?

New review of the pathogenetic and therapeutic implications shows that both diseases share similar complications…. 


Do Contraceptives Cause Gestational Diabetes in Women?

Women who had been on hormonal contraceptives before conception were 1.43 times more likely to develop gestational diabetes during pregnancy compared to women who were not on contraceptives, researchers found....


Comparing Weekly Dulaglutide to Daily Liraglutide

The positives and negative effects of new anti-diabetic agents....


EYLEA® (aflibercept) Injection Receives FDA Approval for the Treatment of Diabetic Macular Edema

Diabetic macular edema (DME) is a leading cause of vision loss among working-age adults.... 


Brown Fat May Cut Odds for Obesity, Diabetes

In a study, patients with differing levels of brown fat cells were exposed to mild cold to stimulate the cells' activity....


Does Diabetes Increase Risk for Head and Neck Cancer?

The risk for head and neck cancer (HNC) was almost 50% higher in patients with diabetes....


HbA1c Increases with Age

HbA1c levels in the elderly rise but not in precise relationship to glucose tolerance....


Telemedicine Improves Metabolic Control in Type 1 Diabetes Patients

HbA1c, knowledge, and self-care treatment adherence significantly improved.... 


Brain Switch That Controls Glucose Levels Discovered

Researchers identified the mechanism in the brain that is key to sensing glucose levels....


High Physical Activity and Low Sitting Time Reduces Obesity and Diabetes Risk

Adults who reported high levels of physical activity combined with low leisure time spent sitting were at a much lower risk for incident obesity after 5 years.... 


Fruits and Vegetables: How Much Consumption is Enough?

In a large meta-analysis of over 800,000 participants' dietary habits, researchers concluded….


Regression from Prediabetes to Normal Glucose Reduces CVD Risk

But risk for CVD was higher in the prediabetes group than for those who already had diabetes, probably due to increased medication…. 


Salty Diet Tied to Heart Risk in Type 2 Diabetes

Patients in the top quartile of salt consumption had a 2.07-fold higher risk of CVD than the lowest quartile.... 


Transcutaneous Electrical Nerve Stimulator (TENS) for Pain Management

Recently cleared by the FDA, a new device available over the counter may help those suffering from chronic pain.... 


Smart Contact Lens for Glucose Monitoring

Google and Novartis/Alcon have agreed to collaborate upon the development of a smart contact lens for medical use.... 



Navigate through our listing of Items for the Week articles here.
Next Last

8827 Total articles for Items for the Week


Browse our other news categories below.
A. Lee Dellon, MD | Aaron I. Vinik, MD, PhD, FCP, MACP | Beverly Price | Charles W Martin, DD | Derek Lowe, PhD | Dr. Bernstein | Dr. Brian Jakes, Jr. | Dr. Fred Pescatore | Dr. Tom Burke, Ph.D | Eric S. Freedland | Evan D. Rosen | Ginger Kanzer-Lewis | Greg Milliger | Kristina Sandstedt | Laura Plunkett | Leonard Lipson, M.A. | Louis H. Philipson | Maria Emanuel Ryan, DDS, PhD | Marilyn Porter, RD, CDE | Melissa Diane Smith | Michael R. Cohen, RPh, MS, ScD, FASHP | Paul Chous, M.A., OD | Philip A. Wood PhD | R. Keith Campbell, Professor, B.Pharm, MBA, CDE | Sheri R. Colberg PhD | Sherri Shafer | Stanley Schwartz, MD, FACP, FACE | Steve Pohlit | Steven V. Edelman, M.D. | Timothy S. Hollingshead |

Looking for a particular Newsletter Issue? Click Here

2014 Most Popular Articles:

Low-carb Diet Recommended for Type 1 and 2 Diabetes Patients
Posted August 01, 2014
New Combination of Diabetes Drugs Have Synergistic Effect
Posted August 08, 2014
Statin Adherence Linked to New Onset Diabetes Risk
Posted July 25, 2014
New Encapsulated Beta-Cell Replacement Therapy for Type 1 Diabetes
Posted August 08, 2014
HbA1c Increases with Age
Posted August 01, 2014
Regression from Prediabetes to Normal Glucose Reduces CVD Risk
Posted July 25, 2014
Connection between Type 1 Diabetes and Ulcerative Colitis?
Posted August 01, 2014
FDA Approves J&J's Invokamet Combo (SGLT-2 + Metformin)
Posted August 15, 2014
Comparing Weekly Dulaglutide to Daily Liraglutide
Posted August 01, 2014
New Way to Regenerate Beta Cells in Type 1 Diabetes Patients
Posted August 08, 2014


Browse by Feature Writer & Article Category.
A. Lee Dellon, MD | Aaron I. Vinik, MD, PhD, FCP, MACP | Beverly Price | Charles W Martin, DD | Derek Lowe, PhD | Dr. Bernstein | Dr. Brian Jakes, Jr. | Dr. Fred Pescatore | Dr. Tom Burke, Ph.D | Eric S. Freedland | Evan D. Rosen | Ginger Kanzer-Lewis | Greg Milliger | Kristina Sandstedt | Laura Plunkett | Leonard Lipson, M.A. | Louis H. Philipson | Maria Emanuel Ryan, DDS, PhD | Marilyn Porter, RD, CDE | Melissa Diane Smith | Michael R. Cohen, RPh, MS, ScD, FASHP | Paul Chous, M.A., OD | Philip A. Wood PhD | R. Keith Campbell, Professor, B.Pharm, MBA, CDE | Sheri R. Colberg PhD | Sherri Shafer | Stanley Schwartz, MD, FACP, FACE | Steve Pohlit | Steven V. Edelman, M.D. | Timothy S. Hollingshead |

Cast Your Vote
Do you recommend SGLT-2 drugs for type 1 diabetes?
CME/CE of the Week
Joyce Black, RN, PhD, CWCN

Category: Wound Care
Credits: 1.0


Advertisement


Search Articles On Diabetes In Control